The DOI matches its Crossref record; 36 of the 36 references it cites were found in a registry or an index.
Clinical Framework and Medical Countermeasure Use During an Anthrax Mass-Casualty Incident: CDC Recommendations
Abstract
In 2014, CDC published updated guidelines for the prevention and treatment of anthrax (Hendricks KA, Wright ME, Shadomy SV, et al. Centers for Disease Control and Prevention expert panel meetings on prevention and treatment of anthrax in adults. Emerg Infect Dis 2014;20[2]. Available at http://wwwnc.cdc.gov/eid/article/20/2/13-0687_article.htm). These guidelines provided recommended best practices for the diagnosis and treatment of persons with naturally occurring or bioterrorism-related anthrax in conventional medical settings. An aerosolized release of Bacillus anthracis spores over densely populated areas could become a mass-casualty incident. To prepare for this possibility, the U.S. government has stockpiled equipment and therapeutics (known as medical countermeasures [MCMs]) for anthrax prevention and treatment. However, previously developed, publicly available clinical recommendations have not addressed the use of MCMs or clinical management during an anthrax mass-casualty incident, when the number of patients is likely to exceed the ability of the health care infrastructure to provide conventional standards of care and supplies of MCMs might be inadequate to meet the demand required. To address this gap, in 2013, CDC conducted a series of systematic reviews of the scientific literature on anthrax to identify evidence that could help clinicians and public health authorities set guidelines for intravenous antimicrobial and antitoxin use, diagnosis of anthrax meningitis, and management of common anthrax-specific complications in the setting of a mass-casualty incident. Evidence from these reviews was presented to professionals with expertise in anthrax, critical care, and disaster medicine during a series of workgroup meetings that were held from August 2013 through March 2014. In March 2014, a meeting was held at which 102 subject matter experts discussed the evidence and adapted the existing best practices guidance to a clinical use framework for the judicious, efficient, and rational use of stockpiled MCMs for the treatment of anthrax during a mass-casualty incident, which is described in this report. This report addresses elements of hospital-based acute care, specifically antitoxins and intravenous antimicrobial use, and the diagnosis and management of common anthrax-specific complications during a mass-casualty incident. The recommendations in this report should be implemented only after predefined triggers have been met for shifting from conventional to contingency or crisis standards of care, such as when the magnitude of cases might lead to impending shortages of intravenous antimicrobials, antitoxins, critical care resources (e.g., chest tubes and chest drainage systems), or diagnostic capability. This guidance does not address primary triage decisions, anthrax postexposure prophylaxis, hospital bed or workforce surge capacity, or the logistics of dispensing MCMs. Clinicians, hospital administrators, state and local health officials, and planners can use these recommendations to assist in the development of crisis protocols that will ensure national preparedness for an anthrax mass-casualty incident.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Surviving Sepsis Campaign: International Guidelines for Management of Severe Sepsis and Septic Shock
Dellinger, R. P., Levy, M. M., Rhodes, A., Annane, D., Gerlach, H., Opal, S. M., Sevransky, J. E., Sprung, C. L., Douglas, I. S., Jaeschke, R., et al. (2013) · Critical Care Medicine · doi:10.1097/ccm.0b013e31827e83af · Cited by 9,694
The Surviving Sepsis Campaign Guidelines Committee including The Pediatric Subgroup*, Dellinger, R. P., Levy, M. M., Rhodes, A., Annane, D., Gerlach, H., Opal, S. M., Sevransky, J. E., Sprung, C. L., Douglas, I. S., et al. (2013) · Intensive Care Medicine · doi:10.1007/s00134-012-2769-8 · Cited by 7,290
Goldstein, B., Giroir, B., & Randolph, A. (2005) · Pediatric Critical Care Medicine · doi:10.1097/01.pcc.0000149131.72248.e6 · Cited by 3,612
Anthrax as a Biological Weapon, 2002: Updated Recommendations for Management
Inglesby, T. V., O'Toole, T., Henderson, D. A., Bartlett, J. G., Ascher, M. S., Eitzen, E., Friedlander, A. M., Gerberding, J., Hauer, J., Hughes, J., et al. (2002) · JAMA · doi:10.1001/jama.287.17.2236 · Cited by 1,027
The Sverdlovsk Anthrax Outbreak of 1979
Meselson, M., Guillemin, J., Hugh-Jones, M., Langmuir, A., Popova, I., Shelokov, A., & Yampolskaya, O. (1994) · Science · doi:10.1126/science.7973702 · Cited by 1,006
Bioterrorism-Related Inhalational Anthrax: The First 10 Cases Reported in the United States
Jernigan, J. A., Stephens, D. S., Ashford, D. A., Omenaca, C., Topiel, M. S., Galbraith, M., Tapper, M., Fisk, T. L., Zaki, S., Popovic, T., et al. (2001) · Emerging Infectious Diseases · doi:10.3201/eid0706.010604 · Cited by 999
Kourtis, A. P., Read, J. S., & Jamieson, D. J. (2014) · New England Journal of Medicine · doi:10.1056/nejmra1213566 · Cited by 850
Identification of the cellular receptor for anthrax toxin
Bradley, K. A., Mogridge, J., Mourez, M., Collier, R. J., & Young, J. A. T. (2001) · Nature · doi:10.1038/n35101999 · Cited by 843
Macrophages are sensitive to anthrax lethal toxin through an acid-dependent process.
Friedlander, A. M. (1986) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(17)38364-3 · Cited by 612
Human capillary morphogenesis protein 2 functions as an anthrax toxin receptor
Scobie, H. M., Rainey, G. J. A., Bradley, K. A., & Young, J. A. T. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0431098100 · Cited by 612
Lung ultrasound in critically ill patients: comparison with bedside chest radiography
Xirouchaki, N., Magkanas, E., Vaporidi, K., Kondili, E., Plataki, M., Patrianakos, A., Akoumianaki, E., & Georgopoulos, D. (2011) · Intensive Care Medicine · doi:10.1007/s00134-011-2317-y · Cited by 474
(1997) · Emerging Infectious Diseases · doi:10.3201/eid0302.970201 · Cited by 465
Pathology of inhalational anthrax in 42 cases from the Sverdlovsk outbreak of 1979.
Abramova, F. A., Grinberg, L. M., Yampolskaya, O. V., & Walker, D. H. (1993) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.90.6.2291 · Cited by 410
Mercaldi, C. J., & Lanes, S. F. (2013) · Chest · doi:10.1378/chest.12-0447 · Cited by 377
Systematic Review: A Century of Inhalational Anthrax Cases from 1900 to 2005
Holty, J.-E. C., Bravata, D. M., Liu, H., Olshen, R. A., McDonald, K. M., & Owens, D. K. (2006) · Annals of Internal Medicine · doi:10.7326/0003-4819-144-4-200602210-00009 · Cited by 274
The pathogenesis of anthrax following the administration of spores by the respiratory route
Ross, J. M. (1957) · The Journal of Pathology and Bacteriology · doi:10.1002/path.1700730219 · Cited by 254
Cellular and systemic effects of anthrax lethal toxin and edema toxin
Moayeri, M., & Leppla, S. H. (2009) · Molecular Aspects of Medicine · doi:10.1016/j.mam.2009.07.003 · Cited by 234
Devereaux, A. V., Dichter, J. R., Christian, M. D., Dubler, N. N., Sandrock, C. E., Hick, J. L., Powell, T., Geiling, J. A., Amundson, D. E., Baudendistel, T. E., et al. (2008) · Chest · doi:10.1378/chest.07-2693 · Cited by 225
Christian, M. D., Sprung, C. L., King, M. A., Dichter, J. R., Kissoon, N., Devereaux, A. V., & Gomersall, C. D. (2014) · Chest · doi:10.1378/chest.14-0736 · Cited by 220
Hick, J. L., Einav, S., Hanfling, D., Kissoon, N., Dichter, J. R., Devereaux, A. V., & Christian, M. D. (2014) · Chest · doi:10.1378/chest.14-0733 · Cited by 196
Biddison, L. D., Berkowitz, K. A., Courtney, B., De Jong, C. M. J., Devereaux, A. V., Kissoon, N., Roxland, B. E., Sprung, C. L., Dichter, J. R., Christian, M. D., et al. (2014) · Chest · doi:10.1378/chest.14-0742 · Cited by 175
Fatal Inhalational Anthrax in a 94-Year-Old Connecticut Woman
Barakat, L. A. (2002) · JAMA · doi:10.1001/jama.287.7.863 · Cited by 172
Introduction and Executive Summary
Christian, M. D., Devereaux, A. V., Dichter, J. R., Rubinson, L., & Kissoon, N. “. (2014) · CHEST Journal · doi:10.1378/chest.14-0732 · Cited by 124
Pregnancy rates for U.S. women continue to drop.
Curtin, S. C., Abma, J. C., Ventura, S. J., & Henshaw, S. K. (2013) · PubMed · Cited by 109
Khan, Z., Hulme, J., & Sherwood, N. (2009) · Anaesthesia · doi:10.1111/j.1365-2044.2009.06135.x · Cited by 82
EFFUSIONS INTO BODY CAVITIES IN HYPOTHYROIDISM
Sachdev, Y., & Hall, R. (1975) · The Lancet · doi:10.1016/s0140-6736(75)91571-8 · Cited by 78
Welkos, S. L., Trotter, R. W., Becker, D. M., & Nelson, G. O. (1989) · Microbial Pathogenesis · doi:10.1016/0882-4010(89)90108-3 · Cited by 73
Boyer, A. E., Quinn, C. P., Hoffmaster, A. R., Kozel, T. R., Saile, E., Marston, C. K., Percival, A. L., Plikaytis, B. D., Woolfitt, A. R., Gallegos-Candela, M., et al. (2009) · Infection and Immunity · doi:10.1128/iai.00346-09 · Cited by 71
System-Level Planning, Coordination, and Communication
Dichter, J. R., Kanter, R. K., Dries, D. J., Luyckx, V. A., Lim, M. L., Wilgis, J., Anderson, M. R., Sarani, B., Hupert, N., Mutter, R. L., et al. (2014) · CHEST Journal · doi:10.1378/chest.14-0738 · Cited by 58
Special Considerations for Prophylaxis for and Treatment of Anthrax in Pregnant and Postpartum Women
Meaney‐Delman, D. M., Zotti, M. E., Creanga, A. A., Misegades, L. K., Wako, E., Treadwell, T. A., Messonnier, N. E., Jamieson, D. J., & Women, T. W. O. A. I. P. A. P. (2014) · Emerging infectious diseases · doi:10.3201/eid2002.130611 · Cited by 51
Self-citationAccuracy of Screening for Inhalational Anthrax after a Bioterrorist Attack
Hupert, N., Bearman, G. M., Mushlin, A. I., & Callahan, M. A. (2003) · Annals of Internal Medicine · doi:10.7326/0003-4819-139-5_part_1-200309020-00009 · Cited by 50
Clinical Features that Discriminate Inhalational Anthrax from Other Acute Respiratory Illnesses
Kuehnert, M. J., Doyle, T. J., Hill, H. A., Bridges, C. B., Jernigan, J. A., Dull, P. M., Reissman, D. B., Ashford, D. A., & Jernigan, D. B. (2003) · Clinical Infectious Diseases · doi:10.1086/346035 · Cited by 50
Kuschner, W. G., Pollard, J. B., & Ezeji-Okoye, S. C. (2007) · Hospital Topics · doi:10.3200/htps.85.3.16-25 · Cited by 49
Ascites in cirrhosis: a review of management and complications.
Kuiper, J. J., van Buuren, H. R., & de Man, R. A. (2007) · PubMed · Cited by 40
Prophylaxis and Treatment of Anthrax in Pregnant Women
Meaney‐Delman, D. M., Rasmussen, S. A., Beigi, R. H., Zotti, M. E., Hutchings, Y. L., Bower, W. A., Treadwell, T. A., & Jamieson, D. J. (2013) · Obstetrics and Gynecology · doi:10.1097/aog.0b013e3182a5fdfd · Cited by 30
Self-citationCourtney, B., Sherman, S., & Penn, M. S. (2013) · The Journal of Law Medicine & Ethics · doi:10.1111/jlme.12033 · Cited by 17
Research works printed but not linked: 47
- MacIntyre, 2006, Development of a risk-priority score for category A bioterrorism agents as an aid for public health policy., Mil Med, 171, 589, 10.7205/MILMED.171.7.589 · doi:10.7205/milmed.171.7.589
- Franz, 2009, Preparedness for an anthrax attack., Mol Aspects Med, 30, 503, 10.1016/j.mam.2009.07.002 · doi:10.1016/j.mam.2009.07.002
- Fernelius, 1960, Comparison of graded and quantal virulence tests for Bacillus Anthracis Spores., J Bacteriol, 79, 594, 10.1128/JB.79.4.594-600.1960 · doi:10.1128/jb.79.4.594-600.1960
- Hanna, 1999, Understanding Bacillus anthracis pathogenesis., Trends Microbiol, 7, 180, 10.1016/S0966-842X(99)01507-3 · doi:10.1016/s0966-842x(99)01507-3
- Fish, 1968, Purification and properties of in vitro-produced anthrax toxin components., J Bacteriol, 95, 907, 10.1128/JB.95.3.907-918.1968 · doi:10.1128/jb.95.3.907-918.1968
- Kyriacou, 2004, Clinical predictors of bioterrorism-related inhalational anthrax., Lancet, 364, 449, 10.1016/S0140-6736(04)16769-X · doi:10.1016/s0140-6736(04)16769-x
- Walsh, 2007, A case of naturally acquired inhalation anthrax: clinical care and analyses of anti-protective antigen immunoglobulin G and lethal factor., Clin Infect Dis, 44, 968, 10.1086/512372 · doi:10.1086/512372
- Sprenkle, 2014, Lethal factor and anti-protective antigen IgG levels associated with inhalation anthrax, Minnesota, USA., Emerg Infect Dis, 20, 310, 10.3201/eid2002.130245 · doi:10.3201/eid2002.130245
- Sirisanthana, 2002, Anthrax of the gastrointestinal tract., Emerg Infect Dis, 8, 649, 10.3201/eid0807.020062 · doi:10.3201/eid0807.020062
- Beatty, 2003, Gastrointestinal anthrax: review of the literature., Arch Intern Med, 163, 2527, 10.1001/archinte.163.20.2527 · doi:10.1001/archinte.163.20.2527
- Demirdag, 2003, Cutaneous anthrax in adults: a review of 25 cases in the eastern Anatolian region of Turkey., Infection, 31, 327, 10.1007/s15010-003-3169-3 · doi:10.1007/s15010-003-3169-3
- Doust, 1968, Corticosteroid in treatment of malignant edema of chest wall and neck (anthrax)., Dis Chest, 53, 773, 10.1378/chest.53.6.773 · doi:10.1378/chest.53.6.773
- Davies, 1985, A major epidemic of anthrax in Zimbabwe: the experience at the Beatrice Road Infectious Diseases Hospital, Harare., Cent Afr J Med, 31, 176
- Lanska, 2002, Anthrax meningoencephalitis., Neurology, 59, 327, 10.1212/WNL.59.3.327 · doi:10.1212/wnl.59.3.327
- Institute of Medicine. Finding what works in health care: standards for systematic reviews. Eden J, Levit L, Berg A, Morton S, eds: The National Academies Press; 2011.
- Hendricks KA, Wright ME, Shadomy SV, Centers for Disease Control and Prevention expert panel meetings on prevention and treatment of anthrax in adults. Emerg Infect Dis 2014;20. Available at .10.3201/eid2002.130687 · doi:10.3201/eid2002.130687
- Huang, Antitoxin treatment for inhalation anthrax: a systematic review., Health Security.
- Pillai, antimicrobial treatment for systemic anthrax: analysis of cases from 1945–2014 identified through systematic literature review., Health Security.
- Patel, 2012, Clozapine-induced peripheral and pleural fluid eosinophilia., Ann Pharmacother, 46, e4, 10.1345/aph.1Q642 · doi:10.1345/aph.1q642
- Roy, 2007, Does this patient with a pericardial effusion have cardiac tamponade?, JAMA, 297, 1810, 10.1001/jama.297.16.1810 · doi:10.1001/jama.297.16.1810
- Azam, 2011, Treatment of pericardial disease., Cardiovasc Ther, 29, 308, 10.1111/j.1755-5922.2010.00151.x · DOI
- Loukas, 2012, Pericardiocentesis: a clinical anatomy review., Clin Anat, 25, 872, 10.1002/ca.22032 · doi:10.1002/ca.22032
- McGibbon, 2007, An evidence-based manual for abdominal paracentesis., Dig Dis Sci, 52, 3307, 10.1007/s10620-007-9805-5 · doi:10.1007/s10620-007-9805-5
- Bradley, 2014, Pediatric anthrax clinical management., Pediatrics, 133, e1411, 10.1542/peds.2014-0563 · doi:10.1542/peds.2014-0563
- Institute of Medicine. Crisis standards of care: a systems framework for catastrophic disaster response. Washington, DC: The National Academies Press; 2012.
- Dries, 2014, Special populations: care of the critically ill and injured during pandemics and disasters: CHEST consensus statement., Chest, 146, e75S, 10.1378/chest.14-0737 · doi:10.1378/chest.14-0737
- Tabatabaie, 1993, Bacillus anthracis as a cause of bacterial meningitis., Pediatr Infect Dis J, 12, 1035, 10.1097/00006454-199312000-00020 · doi:10.1097/00006454-199312000-00020
- Berger T, Kassirer M, Aran AA. Injectional anthrax: new presentation of an old disease. Euro Surveill. 2014;19(32):pii=20877. Available at .DOI: 10.2807/1560-7917.ES2014.19.32.20877 · DOI
- Holty, 2006, Anthrax: a systematic review of atypical presentations., Ann Emerg Med, 48, 200, 10.1016/j.annemergmed.2005.11.035 · DOI
- Lincoln, 1964, Haines B. anthrax., Adv Vet Sci, 9, 327
- Yee, 2010, Aerosolized Bacillus anthracis infection in New Zealand white rabbits: natural history and intravenous levofloxacin treatment., Comp Med, 60, 461
- Anaraki, 2008, Investigations and control measures following a case of inhalation anthrax in East London in a drum maker and drummer, October 2008., Euro Surveill, 13, 19076., 10.2807/ese.13.51.19076-en · doi:10.2807/ese.13.51.19076-en
- Klempner, 2010, Case records of the Massachusetts General Hospital. Case 25-2010. A 24-year-old woman with abdominal pain and shock., N Engl J Med, 363, 766, 10.1056/NEJMcpc1003887 · doi:10.1056/nejmcpc1003887
- Rubinson, 2010, MSOFA: An important step forward, but are we spending too much time on the SOFA?, Disaster Med Public Health Prep, 4, 270, 10.1001/dmp.2010.41 · doi:10.1001/dmp.2010.41
- Booth, 2014, Confirmed Bacillus anthracis infection among persons who inject drugs, Scotland, 2009-2010., Emerg Infect Dis, 20, 1452, 10.3201/eid2009.131481 · doi:10.3201/eid2009.131481
- Tabatabaie, 1993, Bacillus anthracis as a cause of bacterial meningitis., Pediatr Infect Dis J, 12, 1035, 10.1097/00006454-199312000-00020 · doi:10.1097/00006454-199312000-00020
- Russell, 2013, Two anthrax cases with soft tissue infection, severe oedema and sepsis in Danish heroin users., BMC Infect Dis, 13, 408, 10.1186/1471-2334-13-408 · doi:10.1186/1471-2334-13-408
- Iserson, 2003, Ethical resource distribution after biological, chemical, or radiological terrorism., Camb Q Healthc Ethics, 12, 455, 10.1017/S0963180103124164 · doi:10.1017/s0963180103124164
- Meaney-Delman, 2012, Anthrax cases in pregnant and postpartum women: a systematic review., Obstet Gynecol, 120, 1439, 10.1097/AOG.0b013e318270ec08 · DOI
- Place, 2007, Bioterrorism-related inhalational anthrax: can extrapolated adult guidelines be applied to a pediatric population?, Biosecur Bioterror, 5, 35, 10.1089/bsp.2006.0011 · doi:10.1089/bsp.2006.0011
- Bravata, 2007, Inhalational, gastrointestinal, and cutaneous anthrax in children: a systematic review of cases: 1900 to 2005., Arch Pediatr Adolesc Med, 161, 896, 10.1001/archpedi.161.9.896 · doi:10.1001/archpedi.161.9.896
- Barr JR, Boyer AE, Hoffmaster AR, Detection and quantification of anthrax toxins by mass spectrometry: application to clinical anthrax [Abstract 77-Mo:160]. International Conference onBacillus anthracis, B cereusandB thuringiensis; August 7–11, 2011; Bruges, Belgium.
- Boyer, 2007, Detection and quantification of anthrax lethal factor in serum by mass spectrometry., Anal Chem, 79, 8463, 10.1021/ac701741s · doi:10.1021/ac701741s
- Boyer, 2011, Lethal factor toxemia and anti-protective antigen antibody activity in naturally acquired cutaneous anthrax., J Infect Dis, 204, 1321, 10.1093/infdis/jir543 · doi:10.1093/infdis/jir543
- Boyer AE, Lins RC, Gallegos M, Kinetics of anthrax toxins, lethal factor and edema factor during inhalation anthrax in rhesus macaques [Abstract 77-Mo:160]. International Conference onBacillus anthracis, B cereusandB thuringiensis; August 7–11, 2011; Bruges, Belgium.
- Boyer AE, Gallegos-Candela M, Lins RC, Relationship between circulating lethal factor, edema factor and toxin complexes during clinical and experimental anthrax [Abstract S8:5:44]. International Conference onBacillus anthracis, B cereusandB thuringiensis; September 1–5, 2013, Victoria, British Columbia, Canada.
- Kammanadiminti, 2014, Combination therapy with antibiotics and anthrax immune globulin intravenous (AIGIV) is potentially more effective than antibiotics alone in rabbit model of inhalational anthrax., PLoS One, 9, e106393, 10.1371/journal.pone.0106393 · doi:10.1371/journal.pone.0106393
Cited by
Approved Antiviral Drugs over the Past 50 Years
De Clercq, E., & Li, G. (2016) · Clinical Microbiology Reviews · doi:10.1128/cmr.00102-15 · Cited by 1,430
Peeling, R. W., Mabey, D., Kamb, M. L., Chen, X.-S., Radolf, J. D., & Benzaken, A. S. (2017) · Nature Reviews Disease Primers · doi:10.1038/nrdp.2017.73 · Cited by 664
Unemo, M., Seifert, H. S., Hook, E. W., Hawkes, S., Ndowa, F., & Dillon, J.-A. R. (2019) · Nature Reviews Disease Primers · doi:10.1038/s41572-019-0128-6 · Cited by 524
Zika virus cell tropism in the developing human brain and inhibition by azithromycin
Retallack, H., Di Lullo, E., Arias, C., Knopp, K. A., Laurie, M. T., Sandoval-Espinosa, C., Mancia Leon, W. R., Krencik, R., Ullian, E. M., Spatazza, J., et al. (2016) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1618029113 · Cited by 506
The Modern Epidemic of Syphilis
Ghanem, K. G., Ram, S., & Rice, P. A. (2020) · New England Journal of Medicine · doi:10.1056/nejmra1901593 · Cited by 476
Metadata
- Authors
- by, P., Bower, W. A., Hendricks, K., Pillai, S., Guarnizo, J., & Meaney-Delman, D.
- Venue
- MMWR. Recommendations and Reports
- Published
- 2015-12-04
- Volume
- 64
- Issue
- 4
- Pages
- 1-22
- ISSN
- 1057-5987 (ISSN-L)
- 1545-8601
- OpenAlex
- W2416229675
- Cited by
- 585
- References
- 36
- FWCI
- 34.87
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.